Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) EPS (Weighted Average and Diluted) (2023 - 2026)

Profound Medical has reported EPS (Weighted Average and Diluted) over the past 3 years, most recently at $0.27 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 50.0% year-over-year to $0.27; the TTM value through Dec 2025 reached $1.41, up 27.03%, while the annual FY2025 figure was $1.41, 25.89% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.27 at Profound Medical, up from $0.26 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.52 in Q2 2025 and troughed at -$2.25 in Q4 2023.
  • A 3-year average of $0.03 and a median of $0.27 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 107.99% in 2024 and later plummeted 31.58% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$2.25 in 2023, then soared by 107.99% to $0.18 in 2024, then skyrocketed by 50.0% to $0.27 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PROF at $0.27 in Q4 2025, $0.26 in Q3 2025, and $0.52 in Q2 2025.